We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
Cap. Flow
+$512M
Cap. Flow %
1.04%
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85

Sector Composition

Rank Sector Weight
1 Financials 16.9%
2 Technology 16.24%
3 Healthcare 13.01%
4 Industrials 10.83%
5 Consumer Discretionary 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSIT icon
2776
GSI Technology
GSIT
$201M
$98K ﹤0.01%
12,280
-239
-2% -$1.81K
MFIC icon
2777
MidCap Financial Investment
MFIC
$801M
$95K ﹤0.01%
5,612
+22
+0.4% +$395
OCUL icon
2778
Ocular Therapeutix
OCUL
$1.83B
$95K ﹤0.01%
21,322
-8,513
-29% -$43.5K
NM
2779
DELISTED
Navios Maritime Holdings Inc.
NM
$95K ﹤0.01%
7,949
-1,359
-15% -$20.7K
RNWK
2780
DELISTED
RealNetworks Inc
RNWK
$95K ﹤0.01%
27,692
-3,628
-12% -$15.8K
SAN icon
2781
Banco Santander
SAN
$191B
$94K ﹤0.01%
15,014
-1,824
-11% -$11.5K
CFMS
2782
DELISTED
Conformis, Inc. Common Stock
CFMS
$93K ﹤0.01%
1,569
-236
-13% -$18.9K
MVIS icon
2783
Microvision
MVIS
$84.8M
$92K ﹤0.01%
56,569
-12,188
-18% -$23.5K
ELVT
2784
DELISTED
Elevate Credit, Inc.
ELVT
$92K ﹤0.01%
12,220
-2,564
-17% -$19K
EPE
2785
DELISTED
EP Energy Corporation
EPE
$92K ﹤0.01%
38,855
-19,499
-33% -$46.6K
RARX
2786
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$91K ﹤0.01%
10,739
-2,280
-18% -$28K
TRVN
2787
DELISTED
Trevena, Inc.
TRVN
$90K ﹤0.01%
90
-15
-14% -$16.3K
XONE
2788
DELISTED
The ExOne Company
XONE
$87K ﹤0.01%
10,359
HNRG icon
2789
Hallador Energy
HNRG
$646M
$85K ﹤0.01%
13,885
-2,856
-17% -$16.1K
NNA
2790
DELISTED
Navios Maritime Acquisition Corporation
NNA
$85K ﹤0.01%
5,105
-706
-12% -$13.3K
ROX
2791
DELISTED
Castle Brands, Inc.
ROX
$84K ﹤0.01%
69,095
-15,510
-18% -$19.3K
MGNI icon
2792
Magnite
MGNI
$2.83B
$82K ﹤0.01%
44,045
-6,709
-13% -$16.8K
NYMX
2793
DELISTED
Nymox Pharmaceutical Corp
NYMX
$82K ﹤0.01%
24,780
-6,172
-20% -$22.5K
FLNT
2794
Fluent
FLNT
$106M
$81K ﹤0.01%
3,082
-407
-12% -$10.8K
MUFG icon
2795
Mitsubishi UFJ Financial
MUFG
$247B
$78K ﹤0.01%
10,721
-504
-4% -$3.44K
CRIS icon
2796
Curis
CRIS
$9.71M
$75K ﹤0.01%
54
-11
-17% -$25.9K
TCS
2797
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$75K ﹤0.01%
1,051
VBIV
2798
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$75K ﹤0.01%
588
SQBG
2799
DELISTED
Sequential Brands Group, Inc.
SQBG
$74K ﹤0.01%
1,036
-177
-15% -$15K
XBIT icon
2800
XBiotech
XBIT
$68.6M
$70K ﹤0.01%
17,671

Similar funds

RhumbLine Advisers's Q4 2017 Portfolio in Review

As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
  • RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
  • RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
  • RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
  • RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
  • RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.

Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.